| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/11/2007 | US7306795 PRO5774 antibodies |
| 12/11/2007 | US7306794 Methods and compositions for the treatment of defects in lipoprotein metabolism |
| 12/11/2007 | US7306793 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 12/11/2007 | US7306791 Comprising Tumor cytotoxic factor-II or Hepatocyte growth factor as an effective ingredient |
| 12/11/2007 | US7306784 Complexing; drug delivery; in situ imaging |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 12/11/2007 | US7306627 Acellular matrix grafts of collagen and elastic fiber |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2294448C Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 12/11/2007 | CA2224426C Cis-9,10-octadecenoamidase |
| 12/11/2007 | CA2221865C Bradykinin analogs as selective thrombin inhibitors |
| 12/11/2007 | CA2188463C Pharmaceutical compositions containing activated protein c-resistant factor v for the treatment of bleeding disorders |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/11/2007 | CA2166003C Method for providing nutrition to the elderly patients |
| 12/06/2007 | WO2007140410A2 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 12/06/2007 | WO2007140249A1 Methods of treating stroke |
| 12/06/2007 | WO2007140230A2 Methods of use and nutritional compositions of touchi extract |
| 12/06/2007 | WO2007140117A1 Compounds and compositions as channel activating protease inhibitors |
| 12/06/2007 | WO2007139921A2 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | WO2007139826A2 Method for elevating prolactin in mammals |
| 12/06/2007 | WO2007139820A2 Inhibition of skp2-cyclin a interaction |
| 12/06/2007 | WO2007139791A2 Compositions and methods for the delivery of oxygen |
| 12/06/2007 | WO2007139767A2 Compositions and methods for the delivery of nitric oxide |
| 12/06/2007 | WO2007139589A1 Sustained release glp-1 receptor modulators |
| 12/06/2007 | WO2007139585A1 Controlled-release formulation |
| 12/06/2007 | WO2007139433A1 Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application |
| 12/06/2007 | WO2007139430A1 Peptide substance stimulating liver tissue regeneration, pharmaceutical composition on its base and the method of its application |
| 12/06/2007 | WO2007139190A1 Immunostimulatory oligonucleotide and pharmaceutical application thereof |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139128A1 Composition for inhibiting the secretion of creatine phosphokinase |
| 12/06/2007 | WO2007139120A1 AMYLOID-β CLEARANCE ENHANCER |
| 12/06/2007 | WO2007138999A1 Glycopeptide antibiotic derivative |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138339A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 12/06/2007 | WO2007138328A2 Novel applications for staphylococcus aureus sbi protein |
| 12/06/2007 | WO2007138236A1 Sheddase enzymes for neuron growth |
| 12/06/2007 | WO2007138225A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | WO2007138224A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | WO2007138199A2 Recombinant or transgenic factor vii composition, each factor vii molecule having two n-glycosylation sites with defined glycan units |
| 12/06/2007 | WO2007138171A1 Bioactive cyclic peptide |
| 12/06/2007 | WO2007138023A1 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 12/06/2007 | WO2007137871A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 12/06/2007 | WO2007137591A2 Hiv vaccine |
| 12/06/2007 | WO2007137456A1 A peptide for preventing or treating liver damage and its derivant and the use |
| 12/06/2007 | WO2007137414A1 Overexpression of integrin linked kinase (ilk) to improve post-infarct remodeling |
| 12/06/2007 | WO2007137400A1 Method and compound for the treatment of valvular stenosis |
| 12/06/2007 | WO2007137342A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | WO2007117337A9 Development of novel antibiotic alternatives |
| 12/06/2007 | WO2007113682A3 Tgf-beta pharmaceutical compositions |
| 12/06/2007 | WO2007112352A3 Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| 12/06/2007 | WO2007109648A3 Compositions and methods for modulating store-operated calcium entry |
| 12/06/2007 | WO2007109056A3 Use of gelsolin to diagnose and treat inflammatory diseases |
| 12/06/2007 | WO2007107748A3 Inhibition of tumour growth |
| 12/06/2007 | WO2007102946A3 Crystalline polypeptides |
| 12/06/2007 | WO2007101252A3 Targeted delivery of pharmaceutical compounds |
| 12/06/2007 | WO2007087570A3 Polymerized hemoglobin media and its use in isolation and transplantation of islet cells |
| 12/06/2007 | WO2007081792A3 Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| 12/06/2007 | WO2007075439A3 Compositions and methods for treating obesity and related metabolic disorders |
| 12/06/2007 | WO2007053533A3 Sodium chloride solution for drug reconstitution or dilution |
| 12/06/2007 | WO2007047791A3 Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| 12/06/2007 | WO2007044375A3 Pth formulations and methods of use |
| 12/06/2007 | WO2007041495A3 Dampening humoral and innate immunity by inhibition of ppgalnact-1 |
| 12/06/2007 | WO2007038466A3 Treatment of bipolar disorder utilizing anti-fungal compositions |
| 12/06/2007 | WO2007035778A3 Cell-support matrix and a method for preparation thereof |
| 12/06/2007 | WO2007016635A3 Process for the purification of coenzyme q10 |
| 12/06/2007 | WO2007016576A3 Human cd59 mutants with modulated complement binding activity |
| 12/06/2007 | WO2007014258A3 Growth hormone secretagogues |
| 12/06/2007 | WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods |
| 12/06/2007 | WO2006138026A3 Stable pharmaceutical compositions including motilin-like peptides |
| 12/06/2007 | WO2006124681A3 Oral drug delivery system and methods of use thereof |
| 12/06/2007 | WO2006113666A3 Amphiphilic polymers and methods of use thereof |
| 12/06/2007 | WO2006086653A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/06/2007 | WO2005072254A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 12/06/2007 | WO2005072141A3 Peptide inhibitors of rhoa signaling |
| 12/06/2007 | WO2005044994A3 High temperature and alkaline stable catalase |
| 12/06/2007 | WO2004074460A3 Nucleotide and protein sequences of coc genes and methods based thereon |
| 12/06/2007 | WO2004052233A3 Canine rankl and methods for preparing and using the same |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282439 Method of Producing a Composite Material, A Composite Material so Produced and Its Application |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070282095 Thrombin Derivatives And Medicinal Composition Containing The Same |
| 12/06/2007 | US20070281890 Fibroblast Growth Factor-13 |
| 12/06/2007 | US20070281889 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070281887 Isoforms of brain natriuretic peptide |
| 12/06/2007 | US20070281886 Retinal pigmented epithelium derived neurotrophic factor |
| 12/06/2007 | US20070281885 deactivate virally encoded enzymes which is for the replication of the virus; protease inhibitor for anti-hepatitis C viral treatment; including other active drugs as interferon, ribavarin, and adamantine |
| 12/06/2007 | US20070281884 Macrocyclic oximyl hepatitis C protease inhibitors |
| 12/06/2007 | US20070281882 stimulating collagen synthesis and proteoglycan (lumican and keratocan) accumulation; Ethyl-3,4-dihydroxybenzoate (EDB) overrides the effects of ascorbate on pepsin resistance and proteoglycan accumulation |
| 12/06/2007 | US20070281881 Methods And Compositions Comprising Non-Peptide Small Molecules That Solubilize Beta Amyloid Peptide Fiber |
| 12/06/2007 | US20070281333 Metal-binding motif compositions and methods |
| 12/06/2007 | US20070281042 Combinations of chromium with antidiabetics for glucose metabolism disorders |
| 12/06/2007 | US20070281041 Compositions and Methods Involving MDA-7 for the Treatment of Cancer |
| 12/06/2007 | US20070281031 Microparticles and methods for production thereof |
| 12/06/2007 | US20070281025 Cholesterol-Interacting Layered Phyllosilicates and Methods of Reducing Hypercholesteremia in a Mammal |